Estrogen: Consequences and implications of human mutations in synthesis and action

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 12, 1999, Pages 4677-4694

  Grumbach, M M ^a   Auchus, R J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN; ESTROGEN RECEPTOR;

ARTICLE; BONE DENSITY; BONE MASS; BONE MATURATION; CARBOHYDRATE METABOLISM; CORONARY ARTERY ATHEROSCLEROSIS; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN SYNTHESIS; GENE MUTATION; GROWTH ACCELERATION; HUMAN; LIPID METABOLISM; MACROORCHIDISM; NONHUMAN; PRIORITY JOURNAL; PSYCHOSEXUAL DEVELOPMENT; PUBERTY; VIRILIZATION;

EID: 0033305733     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.12.4677     Document Type: Article

References (200)

1. Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A
2. Sequence and expression of human estrogen receptor complementary DNA
3. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
4. Expression of the CYP19 (aromatase) gene: An unusual case of alternative promoter usage
5. Aromatase expression in health and disease
6. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
7. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries
8. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom)
9. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens
10. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene
11. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes
12. Mechanism of estrogen action: Lessons from the estrogen receptor-α knockout mouse
13. Estrogen receptor null mice: What have we learned and where will they lead us?
14. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene
15. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
16. Human estrogen receptor β-gene structure, chromosomal localization and expression pattern
17. The complete primary structure of human estrogen receptor β (hER-β) and its heterodimerization with ER-α in vivo and in vitro
18. The estrogen receptor β subtype: A novel mediator of estrogen acton in neuroendocrine systems
19. ERβ: Identification and characterization of a novel human estrogen receptor
20. Putative estrogen receptor β and α mRNA expression in male and female rhesus macaques
21. Tissue distribution of estrogen receptors α (ER-α) and β (ER-β) mRNA in the midgestational human fetus
22. Generation and reproductive phenotypes of mice lacking estrogen receptor β
23. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
24. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
25. Estrogen receptors in human nontarget tissues: Biological and clinical implications
26. Membrane sex-steroid receptors in the brain
27. Estrogen: Nontranscriptional signalling pathway
28. Nongenomic actions of steroid hormones in reproductive tissues
29. Cell membrane and nuclear receptors derive from a single transcript: Studies of ERα and ERβ expressed in CHO cells
30. Role of extraglandular estrogen in human endocrinology
31. DHEA and peripheral androgen and estrogen formation: Intracrinology
32. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: Intracrinology
33. Regulation of estrogen action: Role of 17 beta-hydroxysteroid dehydrogenases
34. Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists
35. Molecular basis of agonism and antagonism in the oestrogen receptor
36. The roles of oestrogen in the male
37. Estrogen receptors α and β form heterodimers on DNA
38. Nuclear-receptor ligands and ligand-binding domains
39. Tripartite steroid hormone receptor pharmacology: Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones
40. From estrogen to receptor: A new pathway for sex hormones in prostate
41. ERβ a novel estrogen receptor offers the potential for new drug development
42. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER α and ER β
43. Hormone regulation of chondrocyte differentiation and endochondral bone formation
44. Induction of growth plate cartilage ossification by basic fibroblast growth factor
45. MMP-9/Gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
46. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
47. The effect of estrogen on aromatase and vascular endothelial growth factor messenger ribonucleic acid in the normal nonhuman primate mammary gland
48. Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
49. 17β-Estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms
50. Dissociation between bone resorption and bone formation m osteopenic transgenic mice
51. Skeletal effects of estrogen
52. Estrogen's boneprotective effects may involve differential IL-1 receptor regulation m human osteoclast-like cells
53. Bone marrow, cytokines, and bone remodeling: Emerging insights into the pathophysiology of osteoporosis
54. A longitudinal evaluation of bone mineral density in adult men with histories of delayed puberty
55. Bone mineral status in prepubertal children with constitutional delay of growth and puberty
56. Normal volumetric bone mineral density and bone turnover in young men with histories of constitutional delay of puberty
57. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men
58. The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: Evidence for a direct role of sex steroids
59. Estrogen markedly increases bone mass in an estrogen deficient young man with aromatase deficiency
60. Effect of testosterone and estradiol in a man with aromatase deficiency
61. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency
62. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. II. Estrogen levels as determined by an ultrasensitive bioassay
63. Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogen in pubertal growth of girls
64. Massive extraglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy
65. Endocrine disorders associated with inappropriately high aromatase expression
66. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription
67. An aromatase-producing sex-cord tumor recruiting in prepubertal gynecomastia
68. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads
69. Puberty: Ontogeny, neuroendocrinology, physiology, and disorders
70. Growth hormones and sex steroid interactions at puberty
71. The growth hormone cascade: Progress and long-term results of growth hormone treatment in growth hormone deficiency
72. Aromatase in human bone tissue
73. Oestrogen formation from androstenedione in human bone
74. Steroid formation in osteoblast-like cells
75. Androstenedione metabolism in cultured human osteoblast-like cells
76. Local estradiol metabolism in osteoblast- and osteoclast-like cells
77. Aromatase in bone cell: Association with osteoporosis in postmenopausal women
78. Osteoblast cells (MG-63 and HOS) have aromatase and 5 alpha-reductase activities
79. Evidence of estrogen receptor in non-human osteoblast-like cells
80. Estrogen binding receptor mRNA and biological response in osteoblast-like osteosarcoma cells
81. Localization of estrogen receptor-α in human and rabbit skeletal tissues
82. Osteoclasts from human giant cell tumors of bone lack estrogen receptors
83. Differential expression of estrogen receptors α and β mRNA during differentiation of human osteoblast SV-HFO cells
84. Demonstration of estrogen receptor-β immunoreactivity in human growth plate cartilage
85. Bone mineral acquisition in adolescence
86. Bone mineral acquisition during adolescence
87. Bone mineral acquisition in healthy Asian, Hispanic, Black, and Caucasian youth: A longitudinal study
88. Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects
89. Bone growth from 11 to 17 years: Relationship to growth, gender and changes with pubertal status including timing of menarche
90. Volumetric bone mineral density in normal subjects, aged 5-27 years
91. Oestrogen deficiency in men: Where are we today?
92. A unitary model for involutional osteoporosis: Estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men
93. Early effects of hormone replacement therapy on bone
94. Does estrogen stimulate osteoblast function in postmenopausal women?
95. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: Impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood
96. Plasma testosterone-binding affinity and testosterone in umbilical cord plasma, late pregnancy, prepubertal children and adults
97. Hormonal changes in puberty. III. Correlation of plasma testosterone, LH, FSH, testicular size, and bone age with male pubertal development
98. Estradiol and testosterone secretion by human, simian, and canine testes, in males with hypogonadism and in male pseudohermaphrodites with the feminizing testes syndrome
99. Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor
100. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay
101. Aromatase in the human testis
102. Human testicular aromatase: Immunocytochemical and biochemical studies
103. Endogenous estrogen production in the young
104. Androgens as anabolic agents for bone
105. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor
106. Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations
107. Androgens and their role in skeletal homeostasis
108. Androgen effects on bone metabolism: Recent progress and controversies
109. Identification of androgen receptors in normal human osteoblast-like cells
110. Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells
111. The localization of androgen receptors in human bone
112. Bone and mineral metabolism in the androgen-resistant (testicular femmized) male rat
113. Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats
114. Androgen resistance and deficiency have different effects on the growing skeleton of the rat
115. Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats
116. Action of androgens vs. estrogens in male skeletal homeostasis
117. Ovarian androgens reduce bone loss, to a minor but significant degree, in rats treated with the anti-oestrogen ICI 182, 780
118. Testosterone stimulates insulin-like growth factor-I and insulin-like growth factor-I-receptor gene expression in the mandibular condyle: A model of endochondral ossification
119. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens
120. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: A key role for bioavailable estrogen
121. From density to structure: Grooving up and growing old on the surfaces of bone
122. High bone density in hyperandrogenic women: Effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement
123. Long term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones
124. The effects of oestrogen exposure on bone mass in male to female transsexuals
125. Origin of estrogen in normal men and in women with testicular feminization
126. Altered bone mineral density in patients with complete androgen insensitivity syndrome
127. Bone mass in androgen-insensitivity syndrome: Response to hormonal replacement therapy
128. Changes in bone mineral density after orchidectomy and hormone replacement therapy in individuals with androgen insensitivity syndrome
129. A role for oestrogens in the male reproductive system
130. Impairment of spermatogenesis in mice lacking a functional aromatase (cyp 19) gene
131. Sex steroid control of gonadotropin secretion in the human male. II. Effects of estradiol administration in normal and GnRH deficient men
132. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol
133. Role of estrogen receptor-α in the pituitary gland
134. Comparative distribution of estrogen receptor-α (ER-α) and β (ER-β) mRNA in the rat pituitary, gonad, and reproductive tract
135. Insulin resistance, secretion and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy
136. Sex steroids and diabetes
137. Sex differences in coronary heart disease: Why are women so superior? The 1995 Ancel Keys Lecture
138. Vascular aspects of oestrogen
139. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women
140. 2 cholesterol levels in normal men
141. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
142. Relationship between serum estradiol levels and the increases in high-density lipoprotein levels in postmenopausal women treated with oral estradiol
143. The protective effects of estrogen on the cardiovascular system
144. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
145. Cardiovascular effects of estrogen: Implications of the discovery of the estrogen receptor subtype β
146. Human vascular smooth muscle cells contain functional estrogen receptor
147. Increased expression of estrogen receptor β mRNA in male blood vessels after vascular injury
148. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells
149. Identification of authentic estrogen receptor in cultured endothelial cells: A potential mechanism for steroid hormone regulation of endothelial function
150. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase
151. Cardiac myocytes and fibroblasts contain functional estrogen receptors
152. The vascular protective effects of estrogen
153. Estrogen, progesterone and vascular reactivity: Potential cellular mechanisms
154. Expression of oestrogen receptor a and β in rat heart: Role of local oestrogen synthesis
155. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene
156. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man
157. Aromatase in the human central nervous system
158. The molecular and neuroanatomical basis for estrogen effects in the central nervous system
159. Expression of CYP19 (aromatase) mRNA in the human temporal lobe
160. The physiology of male sexual behavior
161. Steroid metabolising enzymes in the determination of brain gender
162. Estrogen and the developing mammalian brain
163. Developmental regulation of sex differences in the brain: Can the role of gonadal steroids be defined?
164. Masculine sexual behavior is disrupted in male and female mice lacking a functional estrogen receptor a gene
165. Behavioral effects of estrogen receptor gene disruption m male mice
166. New insights into the regulation and function of brain estrogen synthase (aromatase)
167. Prenatal hormones organize sex differences of the neuroendocrine reproductive system: Observations on guinea pigs and nonhuman primates
168. Aromatase immunoreactivity in axon terminals of the vertebrate brain. An immunocytochemical study on quail, rat, monkey, and human tissues
169. A review of brain aromatase cytochrome P450
170. Molecular aspects of brain aromatase cytochrome P450
171. The comparative distribution of estrogen receptor-α and β mRNA in the rat central nervous system
172. Responses in the brain of estrogen receptor α-disrupted mice
173. The distribution of estrogen receptor-β mRNA in forebrain regions of the estrogen receptor-α knockout mouse
174. Membrane-initiated steroid actions and the proteins which mediate them
175. Estrogen actions in the central nervous system
176. Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease
177. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
178. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks
179. A new cause of female pseudohermaphroditism: Placental aromatase deficiency
180. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency
181. Female pseudohermaphroditism (FPH) resulting from aromatase (P450 arom) deficiency associated with a novel mutation (R457) in the CYP19 gene
182. Female pseudohermaphrodism associated with a novel homozygous G-to-A (V370-to-M) substitution in the P-450 aromatase gene
183. Normal female infants born of mothers with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency
184. Increasing aromatase cytochrome P-450 level in human placenta during pregnancy: Studied by immunohistochemistry and enzyme-linked immunosorbent assay
185. Female masculinization in the spotted hyena: Physiology, evolution and behavioral ecology
186. Hormonal correlates of masculinization' in the female spotted hyaena (Crocuta crocuta). I. Infancy through sexual maturity
187. Androgens and masculinization of genitalia in the spotted hyaena (Crocuta crocuta). 1. Urogenital morphology and placental androgen production during fetal life
188. A mechanism for virilization of female spotted hyenas in utero
189. Androgens and masculinization of genital a in the spotted hyaena (Crocuta crocuta). Effects of prenatal antiandrogens
190. A three-dimensional model of aromatase cytochrome P450
191. Point mutation Arg440 to His in cytochrome P450c17 causes severe 17α-hydroxylase deficiency
192. Structure and function of cytochromes P450: A comparative analysis of three crystal structures
193. Structural alignments of P450s and extrapolations to the unknown
194. Disorders of sex differentiation
195. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice
196. Normal growth and development in the absence of hepatic insulin-like growth factor I
197. Estrogen metabolism